Jade Biosciences is developing a pipeline of potentially best-in-class therapies aimed at transforming the standard of care for patients living with autoimmune diseases.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.10.2024 | - | $95M | - |
Mentions in press and media 3
| Date | Title | Description |
| 24.10.2024 | Jade Biosciences Extends Financing; Total To $95M | Jade Biosciences, a Vancouver, BC, Canada-based biotechnology company dedicated to developing therapies for patients living with autoimmune diseases, extended its financing, bringing the total raised to $95M.
The round added Frazier Life Sc... |
| 01.08.2024 | Jade Biosciences Launches With $80M |
WALTHAM, MA, Jade Biosciences, a biotechnology company dedicated to developing best-in-class therapies for patients living with autoimmune diseases, today announced the closing of an $80 million financing.
>> Click here for more fund... |
| - | Jade Biosciences | “Jade Biosciences is developing a pipeline of best-in-class therapies to redefine standard of care for patients living with autoimmune conditions.” |
Reviews 0
